Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2004 Jun 15;380(Pt 3):735–747. doi: 10.1042/BJ20031281

Co-operative interactions between NFAT (nuclear factor of activated T cells) c1 and the zinc finger transcription factors Sp1/Sp3 and Egr-1 regulate MT1-MMP (membrane type 1 matrix metalloproteinase) transcription by glomerular mesangial cells.

Maria Alejandra Alfonso-Jaume 1, Rajeev Mahimkar 1, David H Lovett 1
PMCID: PMC1224202  PMID: 14979875

Abstract

The transition of normally quiescent glomerular MCs (mesangial cells) to a highly proliferative phenotype with characteristics of myofibroblasts is a process commonly observed in inflammatory diseases affecting the renal glomerulus, the ultimate result of which is glomerulosclerosis. Generation of proteolytically active MMP (matrix metalloproteinase)-2 by the membrane-associated membrane type 1 (MT1)-MMP is responsible for the transition of mesangial cells to the myofibroblast phenotype [Turck, Pollock, Lee, Marti and Lovett (1996) J. Biol. Chem. 271, 15074-15083]. In the present study, we show that the expression of MT1-MMP within the context of MCs is mediated by three discrete cis -acting elements: a proximal non-canonical Sp1 site that preferentially binds Sp1; an overlapping Sp1/Egr-1-binding site that preferentially binds Egr-1; and a more distal binding site for the NFAT (nuclear factor of activated T cells) that binds the NFAT c1 isoform present in MC nuclear extracts. Transfection with an NFAT c1 expression plasmid, or activation of calcineurin with a calcium ionophore, yielded major increases in NFAT c1 nuclear DNA-binding activity, MT1-MMP transcription and protein synthesis, which were additive with the lower levels of transactivation provided by the proximal Sp1 and the overlapping Sp1/Egr-1 sites. Specific binding of NFAT c1 to the MT1-MMP promoter was confirmed by chromatin immunoprecipitation studies, while MT1-MMP expression was suppressed by treatment with the calcineurin inhibitor, cyclosporin A. These studies are the first demonstration that a specific NFAT isoform enhances transcription of an MMP (MT1-MMP) that plays a major role in the proteolytic events that are a dominant feature of acute glomerular inflammation. Suppression of MT1-MMP by commonly used calcineurin inhibitors may play a role in the development of renal fibrosis following renal transplantation.

Full Text

The Full Text of this article is available as a PDF (741.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baricos W. H., Murphy G., Zhou Y. W., Nguyen H. H., Shah S. V. Degradation of glomerular basement membrane by purified mammalian metalloproteinases. Biochem J. 1988 Sep 1;254(2):609–612. doi: 10.1042/bj2540609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bert A. G., Burrows J., Hawwari A., Vadas M. A., Cockerill P. N. Reconstitution of T cell-specific transcription directed by composite NFAT/Oct elements. J Immunol. 2000 Nov 15;165(10):5646–5655. doi: 10.4049/jimmunol.165.10.5646. [DOI] [PubMed] [Google Scholar]
  3. Carl Marina, Akagi Yoshitaka, Weidner Sven, Isaka Yoshitaka, Imai Enyu, Rupprecht Harald D. Specific inhibition of Egr-1 prevents mesangial cell hypercellularity in experimental nephritis. Kidney Int. 2003 Apr;63(4):1302–1312. doi: 10.1046/j.1523-1755.2003.00865.x. [DOI] [PubMed] [Google Scholar]
  4. Cheng Sunfa, Alfonso-Jaume Maria Alexandra, Mertens Peter R., Lovett David H. Tumour metastasis suppressor, nm23-beta, inhibits gelatinase A transcription by interference with transactivator Y-box protein-1 (YB-1). Biochem J. 2002 Sep 15;366(Pt 3):807–816. doi: 10.1042/BJ20020202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Crabtree G. R. Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell. 1999 Mar 5;96(5):611–614. doi: 10.1016/s0092-8674(00)80571-1. [DOI] [PubMed] [Google Scholar]
  6. Davies M., Martin J., Thomas G. J., Lovett D. H. Proteinases and glomerular matrix turnover. Kidney Int. 1992 Mar;41(3):671–678. doi: 10.1038/ki.1992.103. [DOI] [PubMed] [Google Scholar]
  7. Decker Eva L., Nehmann Nina, Kampen Eva, Eibel Hermann, Zipfel Peter F., Skerka Christine. Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression. Nucleic Acids Res. 2003 Feb 1;31(3):911–921. doi: 10.1093/nar/gkg186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983 Mar 11;11(5):1475–1489. doi: 10.1093/nar/11.5.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Edwards D. R., Murphy G., Reynolds J. J., Whitham S. E., Docherty A. J., Angel P., Heath J. K. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 1987 Jul;6(7):1899–1904. doi: 10.1002/j.1460-2075.1987.tb02449.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gashler A., Sukhatme V. P. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog Nucleic Acid Res Mol Biol. 1995;50:191–224. doi: 10.1016/s0079-6603(08)60815-6. [DOI] [PubMed] [Google Scholar]
  11. Haas T. L., Stitelman D., Davis S. J., Apte S. S., Madri J. A. Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium. J Biol Chem. 1999 Aug 6;274(32):22679–22685. doi: 10.1074/jbc.274.32.22679. [DOI] [PubMed] [Google Scholar]
  12. Harendza S., Pollock A. S., Mertens P. R., Lovett D. H. Tissue-specific enhancer-promoter interactions regulate high level constitutive expression of matrix metalloproteinase 2 by glomerular mesangial cells. J Biol Chem. 1995 Aug 11;270(32):18786–18796. doi: 10.1074/jbc.270.32.18786. [DOI] [PubMed] [Google Scholar]
  13. Hayashi K., Horikoshi S., Osada S., Shofuda K., Shirato I., Tomino Y. Macrophage-derived MT1-MMP and increased MMP-2 activity are associated with glomerular damage in crescentic glomerulonephritis. J Pathol. 2000 Jul;191(3):299–305. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH637>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  14. Hayashi K., Osada S., Shofuda K., Horikoshi S., Shirato I., Tomino Y. Enhanced expression of membrane type-1 matrix metalloproteinase in mesangial proliferative glomerulonephritis. J Am Soc Nephrol. 1998 Dec;9(12):2262–2271. doi: 10.1681/ASN.V9122262. [DOI] [PubMed] [Google Scholar]
  15. Hofer G., Grimmer C., Sukhatme V. P., Sterzel R. B., Rupprecht H. D. Transcription factor Egr-1 regulates glomerular mesangial cell proliferation. J Biol Chem. 1996 Nov 8;271(45):28306–28310. doi: 10.1074/jbc.271.45.28306. [DOI] [PubMed] [Google Scholar]
  16. Horsley Valerie, Pavlath Grace K. NFAT: ubiquitous regulator of cell differentiation and adaptation. J Cell Biol. 2002 Mar 4;156(5):771–774. doi: 10.1083/jcb.200111073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Imai K., Ohuchi E., Aoki T., Nomura H., Fujii Y., Sato H., Seiki M., Okada Y. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res. 1996 Jun 15;56(12):2707–2710. [PubMed] [Google Scholar]
  18. Jauliac Sebastien, López-Rodriguez Cristina, Shaw Leslie M., Brown Lawrence F., Rao Anjana, Toker Alex. The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol. 2002 Jul;4(7):540–544. doi: 10.1038/ncb816. [DOI] [PubMed] [Google Scholar]
  19. Khachigian L. M., Williams A. J., Collins T. Interplay of Sp1 and Egr-1 in the proximal platelet-derived growth factor A-chain promoter in cultured vascular endothelial cells. J Biol Chem. 1995 Nov 17;270(46):27679–27686. doi: 10.1074/jbc.270.46.27679. [DOI] [PubMed] [Google Scholar]
  20. Lin J. X., Leonard W. J. The immediate-early gene product Egr-1 regulates the human interleukin-2 receptor beta-chain promoter through noncanonical Egr and Sp1 binding sites. Mol Cell Biol. 1997 Jul;17(7):3714–3722. doi: 10.1128/mcb.17.7.3714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lohi J., Lehti K., Valtanen H., Parks W. C., Keski-Oja J. Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene. Gene. 2000 Jan 25;242(1-2):75–86. doi: 10.1016/s0378-1119(99)00549-1. [DOI] [PubMed] [Google Scholar]
  22. Lovett D. H., Johnson R. J., Marti H. P., Martin J., Davies M., Couser W. G. Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis. Am J Pathol. 1992 Jul;141(1):85–98. [PMC free article] [PubMed] [Google Scholar]
  23. Macián F., López-Rodríguez C., Rao A. Partners in transcription: NFAT and AP-1. Oncogene. 2001 Apr 30;20(19):2476–2489. doi: 10.1038/sj.onc.1204386. [DOI] [PubMed] [Google Scholar]
  24. Majello B., De Luca P., Lania L. Sp3 is a bifunctional transcription regulator with modular independent activation and repression domains. J Biol Chem. 1997 Feb 14;272(7):4021–4026. doi: 10.1074/jbc.272.7.4021. [DOI] [PubMed] [Google Scholar]
  25. Maquoi E., Frankenne F., Baramova E., Munaut C., Sounni N. E., Remacle A., Noël A., Murphy G., Foidart J. M. Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines. J Biol Chem. 2000 Apr 14;275(15):11368–11378. doi: 10.1074/jbc.275.15.11368. [DOI] [PubMed] [Google Scholar]
  26. McLennan S. V., Martell S. Y., Yue D. K. High glucose concentration inhibits the expression of membrane type metalloproteinase by mesangial cells: possible role in mesangium accumulation. Diabetologia. 2000 May;43(5):642–648. doi: 10.1007/s001250051353. [DOI] [PubMed] [Google Scholar]
  27. McMillan J. I., Riordan J. W., Couser W. G., Pollock A. S., Lovett D. H. Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest. 1996 Feb 15;97(4):1094–1101. doi: 10.1172/JCI118502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Mertens P. R., Alfonso-Jaume M. A., Steinmann K., Lovett D. H. A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription. J Biol Chem. 1998 Dec 4;273(49):32957–32965. doi: 10.1074/jbc.273.49.32957. [DOI] [PubMed] [Google Scholar]
  29. Mertens P. R., Alfonso-Jaume M. A., Steinmann K., Lovett D. H. YB-1 regulation of the human and rat gelatinase A genes via similar enhancer elements. J Am Soc Nephrol. 1999 Dec;10(12):2480–2487. doi: 10.1681/ASN.V10122480. [DOI] [PubMed] [Google Scholar]
  30. Mertens P. R., Harendza S., Pollock A. S., Lovett D. H. Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1. J Biol Chem. 1997 Sep 5;272(36):22905–22912. doi: 10.1074/jbc.272.36.22905. [DOI] [PubMed] [Google Scholar]
  31. Myers B. D., Ross J., Newton L., Luetscher J., Perlroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med. 1984 Sep 13;311(11):699–705. doi: 10.1056/NEJM198409133111103. [DOI] [PubMed] [Google Scholar]
  32. Northrop J. P., Ho S. N., Chen L., Thomas D. J., Timmerman L. A., Nolan G. P., Admon A., Crabtree G. R. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature. 1994 Jun 9;369(6480):497–502. doi: 10.1038/369497a0. [DOI] [PubMed] [Google Scholar]
  33. Ohuchi E., Imai K., Fujii Y., Sato H., Seiki M., Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem. 1997 Jan 24;272(4):2446–2451. doi: 10.1074/jbc.272.4.2446. [DOI] [PubMed] [Google Scholar]
  34. Okada A., Bellocq J. P., Rouyer N., Chenard M. P., Rio M. C., Chambon P., Basset P. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2730–2734. doi: 10.1073/pnas.92.7.2730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Peng S. L., Gerth A. J., Ranger A. M., Glimcher L. H. NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity. 2001 Jan;14(1):13–20. doi: 10.1016/s1074-7613(01)00085-1. [DOI] [PubMed] [Google Scholar]
  36. Pulyaeva H., Bueno J., Polette M., Birembaut P., Sato H., Seiki M., Thompson E. W. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin Exp Metastasis. 1997 Mar;15(2):111–120. doi: 10.1023/a:1018444609098. [DOI] [PubMed] [Google Scholar]
  37. Rao A., Luo C., Hogan P. G. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol. 1997;15:707–747. doi: 10.1146/annurev.immunol.15.1.707. [DOI] [PubMed] [Google Scholar]
  38. Rao Velidi H., Lees George E., Kashtan Clifford E., Nemori Ryochi, Singh Rakesh K., Meehan Daniel T., Rodgers Kathyrn, Berridge Brian R., Bhattacharya Gautam, Cosgrove Dominic. Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS). Kidney Int. 2003 May;63(5):1736–1748. doi: 10.1046/j.1523-1755.2003.00939.x. [DOI] [PubMed] [Google Scholar]
  39. Santini M. P., Talora C., Seki T., Bolgan L., Dotto G. P. Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation. Proc Natl Acad Sci U S A. 2001 Aug 7;98(17):9575–9580. doi: 10.1073/pnas.161299698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 1994 Jul 7;370(6484):61–65. doi: 10.1038/370061a0. [DOI] [PubMed] [Google Scholar]
  41. Shiomi Takayuki, Okada Yasunori. MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):145–152. doi: 10.1023/a:1023039230052. [DOI] [PubMed] [Google Scholar]
  42. Solberg H., Løber D., Eriksen J., Ploug M., Rønne E., Behrendt N., Danø K., Høyer-Hansen G. Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator. Eur J Biochem. 1992 Apr 15;205(2):451–458. doi: 10.1111/j.1432-1033.1992.tb16799.x. [DOI] [PubMed] [Google Scholar]
  43. Sounni N. E., Devy L., Hajitou A., Frankenne F., Munaut C., Gilles C., Deroanne C., Thompson E. W., Foidart J. M., Noel A. MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J. 2002 Apr;16(6):555–564. doi: 10.1096/fj.01-0790com. [DOI] [PubMed] [Google Scholar]
  44. Srivastava S., Weitzmann M. N., Kimble R. B., Rizzo M., Zahner M., Milbrandt J., Ross F. P., Pacifici R. Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1. J Clin Invest. 1998 Nov 15;102(10):1850–1859. doi: 10.1172/JCI4561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sugimoto T., Haneda M., Sawano H., Isshiki K., Maeda S., Koya D., Inoki K., Yasuda H., Kashiwagi A., Kikkawa R. Endothelin-1 induces cyclooxygenase-2 expression via nuclear factor of activated T-cell transcription factor in glomerular mesangial cells. J Am Soc Nephrol. 2001 Jul;12(7):1359–1368. doi: 10.1681/ASN.V1271359. [DOI] [PubMed] [Google Scholar]
  46. Turck J., Pollock A. S., Lee L. K., Marti H. P., Lovett D. H. Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation. J Biol Chem. 1996 Jun 21;271(25):15074–15083. doi: 10.1074/jbc.271.25.15074. [DOI] [PubMed] [Google Scholar]
  47. Turck J., Pollock A. S., Lovett D. H. Gelatinase A is a glomerular mesangial cell growth and differentiation factor. Kidney Int. 1997 May;51(5):1397–1400. doi: 10.1038/ki.1997.191. [DOI] [PubMed] [Google Scholar]
  48. Yamaguchi Seiichi, Yamaguchi Miho, Yatsuyanagi Eiji, Yun Sang-Soeb, Nakajima Nobuyuki, Madri Joseph A., Sumpio Bauer E. Cyclic strain stimulates early growth response gene product 1-mediated expression of membrane type 1 matrix metalloproteinase in endothelium. Lab Invest. 2002 Jul;82(7):949–956. doi: 10.1097/01.lab.0000020408.77307.e9. [DOI] [PubMed] [Google Scholar]
  49. Yang Teddy T. C., Chow Chi-Wing. Transcription cooperation by NFAT.C/EBP composite enhancer complex. J Biol Chem. 2003 Feb 26;278(18):15874–15885. doi: 10.1074/jbc.M211560200. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES